Literature DB >> 30049466

Relation of Echocardiographic Markers of Left Atrial Fibrosis to Atrial Fibrillation Burden.

Melissa Leung1, Rachid Abou2, Philippe J van Rosendael2, Pieter van der Bijl2, Suzanne E van Wijngaarden2, Madelien V Regeer2, Tomaz Podlesnikar2, Nina Ajmone Marsan2, Dominic Y Leung3, Victoria Delgado2, Jeroen J Bax4.   

Abstract

In patients with atrial fibrillation (AF), left atrial (LA) fibrosis is a major determinant of the progression to, and burden of AF. LA reservoir strain and total atrial conduction time (PA-TDI) reflect LA fibrotic content. We aimed to investigate the relation between LA reservoir strain and PA-TDI in AF patients and control subjects. Six-hundred two patients (mean age 56 years, 53% men) with first episode of AF and 342 controls (mean age 64 years, 71% men) without structural heart disease underwent echocardiography. LA volumes, PA-TDI, LA reservoir strain, and left ventricular global longitudinal strain (GLS) were compared. Compared with controls, patients with paroxysmal AF and patients with persistent AF had longer PA-TDI (128 ± 25 millisecond, 140 ± 31 millisecond, and 154 ± 33 millisecond, respectively; p <0.001) and a progressive decline in LA reservoir strain (36.9 ± 11.6%, 29.8 ± 13.4%, 24.2 ± 12.3%, respectively; p <0.001). LA reservoir strain was negatively correlated with PA-TDI (r = -0.43, p <0.001). On multivariate analyses, LA reservoir strain, diabetes mellitus, and burden of AF were independent correlates of PA-TDI (R2 = 0.23, p <0.001); whereas only PA-TDI was an independent correlate of LA reservoir strain (R2 = 0.43, p <0.001); controlling for age, hypertension, coronary artery disease, body mass index, severity of mitral regurgitation, left ventricular global longitudinal strain, and LA volume. In conclusion, PA-TDI and LA reservoir strain are negatively correlated in all subjects, irrespective of the presence or burden of AF. Patients with persistent AF have longer PA-TDI and impaired LA reservoir strain compared with paroxysmal AF and controls, suggesting increasing burden of fibrosis and LA structural remodeling in the progression of AF.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30049466     DOI: 10.1016/j.amjcard.2018.04.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Detection of atrial fibrosis using echocardiographic strain: a new pathway.

Authors:  Maria Mariana Barros Melo da Silveira; João Victor Batista Cabral; Amanda Tavares Xavier; Lucas Reis da Costa; Dhouglas José Ferreira do Nascimento; José Maria Del Castillo; Luydson Richardson da Silva Vasconcelos; Dário Celestino Sobral Filho; Dinaldo Cavalcanti de Oliveira
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

2.  Left atrial morpho-functional remodeling in atrial fibrillation assessed by three dimensional speckle tracking echocardiography and its value in atrial fibrillation screening.

Authors:  Lilian Bao; Lei Cheng; Xiufang Gao; Fangying Yan; Huihua Fan; Ying Shan; Yong Li; Haiming Shi; Guoqian Huang; Liwen Bao
Journal:  Cardiovasc Ultrasound       Date:  2022-05-03       Impact factor: 2.263

Review 3.  Cardiac Imaging After Ischemic Stroke or Transient Ischemic Attack.

Authors:  S Camen; K G Haeusler; R B Schnabel
Journal:  Curr Neurol Neurosci Rep       Date:  2020-06-30       Impact factor: 5.081

4.  Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction.

Authors:  Ning Zhu; Hao Chen; Xuyong Zhao; Fanhao Ye; Wenbing Jiang; Yi Wang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 5.  New Ultrasound Technologies for Ischemic Heart Disease Assessment and Monitoring in Cardiac Rehabilitation.

Authors:  Antonello D'Andrea; Simona Sperlongano; Mario Pacileo; Elio Venturini; Gabriella Iannuzzo; Marco Gentile; Rossella Sperlongano; Giuseppe Vitale; Marco Maglione; Gennaro Cice; Filippo Maria Sarullo; Anna Di Lorenzo; Carlo Vigorito; Francesco Giallauria; Eugenio Picano
Journal:  J Clin Med       Date:  2020-09-28       Impact factor: 4.964

6.  Impaired Left Atrial Performance Resulting From Age-Related Arial Fibrillation Is Associated With Increased Fibrosis Burden: Insights From a Clinical Study Combining With an in vivo Experiment.

Authors:  Kai-Bin Lin; Kan-Kai Chen; Shuai Li; Ming-Qi Cai; Min-Jie Yuan; Yan-Peng Wang; Xue Zhang; Meng Wei; Mei-Ling Yan; Xin-Xin Ma; Dong-Yan Zheng; Qi-Han Wu; Jing-Bo Li; Dong Huang
Journal:  Front Cardiovasc Med       Date:  2021-02-03

7.  Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive left atrial fibrosis.

Authors:  Luuk H G A Hopman; Mark J Mulder; Anja M van der Laan; Ahmet Demirkiran; Pranav Bhagirath; Albert C van Rossum; Cornelis P Allaart; Marco J W Götte
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-11       Impact factor: 5.364

Review 8.  Echocardiography-derived total atrial conduction time (PA-TDI duration): risk stratification and guidance in atrial fibrillation management.

Authors:  Patrick Müller; Bob Weijs; Nadine M A A Bemelmans; Andreas Mügge; Lars Eckardt; Harry J G M Crijns; Jeroen J Bax; Dominik Linz; Dennis W den Uijl
Journal:  Clin Res Cardiol       Date:  2021-08-28       Impact factor: 5.460

9.  Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery.

Authors:  Farhan Rizvi; Mahek Mirza; Susan Olet; Melissa Albrecht; Stacie Edwards; Larisa Emelyanova; David Kress; Gracious R Ross; Ekhson Holmuhamedov; A Jamil Tajik; Bijoy K Khandheria; Arshad Jahangir
Journal:  Int J Cardiol       Date:  2020-01-07       Impact factor: 4.164

10.  Left atrial strain - an early marker of left ventricular diastolic dysfunction in patients with hypertension and paroxysmal atrial fibrillation.

Authors:  Jonas Jarasunas; Audrius Aidietis; Sigita Aidietiene
Journal:  Cardiovasc Ultrasound       Date:  2018-10-31       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.